Portfolio Lab

uniQure N.V.

  • Stock
  • Ticker QURE
  • ISIN NL0010696654
  • Nasdaq
  • US listing in dollars

Health care · Pharmaceuticals · USA

$19.35 −4.35%
Close of 20 Nov 2026
Open in backtest

Performance, volatility and drawdowns of uniQure N.V. since 11/2016, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.

Performance

QUREGlobal equities (VT)

$10,000 grew to $27,139. Global equities (VT): $29,042.

Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.

Declines from the peak

Lowest point −95.4% in 07/2024, measured from the peak in 06/2019. The old peak has not been reached again yet.

1-year return
−30.6%
5-year return p.a.
−8.2%
10-year return p.a.
+10.5%
Volatility p.a.
126.4%
Largest decline
−95.4%

Financial statements

Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures

Quarter end12/202403/202506/202509/202512/202503/202606/202609/2026
Income statement
Revenue5.21.65.33.75.63.65.85.2
Gross profit4.61.44.63.35.13.35.55.0
Operating income-46-39-44-51-51-46-52-53
EBITDA-41-35-40-47-48-43-47-48
Net income-73-44-38-81-37-54-81-61
Earnings per share-1.50-0.82-0.69-1.38-0.56-0.85-1.22-0.88
Balance sheet
Total assets557605585888825779985941
Liabilities563572589660626629661646
Equity-6.834-4.0229199149324295
Cash1592172545978014041398
Long-term debt5152525250505050
Cash flow
Operating cash flow-53-44-40-16-78-38-29-48
Capital expenditure0.0-0.1-0.30.1-0.1-0.1-0.50.0
Free cash flow-53-44-40-16-78-38-29-48

Value it:DCF calculatorMultiples calculator

Annual returns

Best year 2017 at +249.8%, weakest 2023 at −70.1%. 6 of 9 full years were positive. * partial year.

Quarterly reports

Filing date with the SEC and earnings per share of the quarter

DayEarnings per share
4 Nov 2026−$0.88
29 Jul 2026−$1.22
5 May 2026−$0.85
2 Mar 2026−$0.56
10 Nov 2025−$1.38
29 Jul 2025−$0.69
9 May 2025−$0.82
27 Feb 2025−$1.50
5 Nov 2024−$0.91
1 Aug 2024−$1.16
7 May 2024−$1.36
28 Feb 2024−$1.53

Key metrics

Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.

Valuation

Market cap
€1.2bn
Market cap in trading currency
$1.36bn
Enterprise value
$1.31bn
P/E
–
P/S
67.30
P/B
4.61
EV/Sales
64.91
EV/EBITDA
–
Earnings yield
–
FCF yield
-14.2%

Results (last four quarters)

Revenue
$20.2m
Gross profit
$18.9m
EBITDA
−$186m
Net income
−$233m
Earnings per share
−$3.51
Revenue per share
$0.29
Revenue growth
+40.4%
Earnings growth
–

Profitability

Gross margin
93.9%
Operating margin
-1,001.7%
Net margin
-1,154.8%
Return on equity
-89.0%
Return on assets
-24.8%

Balance sheet and cash flow

Cash
$98.4m
Cash per share
$1.40
Financial debt
$50.3m
Debt/equity %
17
Current ratio
11.52
Book value per share
$4.20
Operating cash flow
−$192m
Free cash flow
−$193m

Dividend

Dividend yield
0.00%
Dividend (12 months)
$0.00
Yield (12 months)
0.00%
Payout ratio
–
Ex-dividend date
–

Shares and trading

Shares outstanding
70.1m
Volume
2.03m
Avg. volume 3 months
2.25m
Relative volume
0.9

Price and technicals

Price
$19.35
1 day
−4.3%
52-week high
$51.05
52-week low
$9.03
Distance to 52-week high
−62.1%
Distance to 52-week low
+114.3%
Distance to 50-day line
−28.5%
Distance to 200-day line
−34.5%
RSI (14)
33
Volatility 1M
83.7%

Performance

1 week
−18.7%
1 month
−16.3%
3 months
−59.2%
6 months
−20.0%
YTD
−19.1%
1 year
−30.8%

Dates

Fiscal year end
31 Dec 2025
Most recent quarter
30 Sep 2026

Frequently asked questions

How has QURE performed since 11/2016?

$10,000 grew to $27,139 by 20 Nov 2026, which is +10.5% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.

How volatile is QURE?

Volatility was 126.4% per year, measured on monthly returns. The largest decline from a peak was −95.4%, with the low in 07/2024.

How does QURE compare with a broad equity ETF?

Over the same period Global equities (VT) returned +11.3% per year at 15.1% volatility, QURE returned +10.5% at 126.4%. The correlation of monthly returns was 0.14; 1 would mean they moved in lockstep.

Which currency are the figures in?

In US dollars, the currency of the US listing.

Why does this page show a US listing?

The figures use the stock's listing traded in the US. On individual days its path differs slightly from the price on the home exchange.

Not investment advice. Metrics and financial statements calculated from the company's mandatory filings with the SEC, without guarantee; amounts in US dollars.

Reference data of securities: source ESMA (FIRDS reference data) and SEC (EDGAR).

Not investment advice: results in Portfolio Lab are model calculations based on historical data and your inputs. Past performance is not a reliable indicator of future results.

uniQure N.V. (QURE): Return and risk | Portfolio Lab